Medical Care
Global Asthma Therapeutics Market Research Report 2025
- Mar 11, 25
- ID: 8153
- Pages: 84
- Figures: 85
- Views: 1
The global market for Asthma Therapeutics was valued at US$ 22880 million in the year 2024 and is projected to reach a revised size of US$ 28630 million by 2031, growing at a CAGR of 3.3% during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Asthma Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Asthma Therapeutics.
The Asthma Therapeutics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Asthma Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Asthma Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
AstraZeneca
Boehringer Ingelheim
F. Hoffmann-La Roche
GSK
Merck
Horizon Pharma
Mitsubishi Tanabe Pharma
Sanofi
Mundipharma
Nycomed
Kissei Pharmaceutical
ALK-Abello
Array BioPharma
SAMA Pharmaceuticals
Whanin Pharmaceutical
Segment by Type
Inhalation
Parenteral
Oral
Segment by Application
Hospitals
Clinics
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Asthma Therapeutics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Asthma Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Asthma Therapeutics.
The Asthma Therapeutics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Asthma Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Asthma Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
AstraZeneca
Boehringer Ingelheim
F. Hoffmann-La Roche
GSK
Merck
Horizon Pharma
Mitsubishi Tanabe Pharma
Sanofi
Mundipharma
Nycomed
Kissei Pharmaceutical
ALK-Abello
Array BioPharma
SAMA Pharmaceuticals
Whanin Pharmaceutical
Segment by Type
Inhalation
Parenteral
Oral
Segment by Application
Hospitals
Clinics
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Asthma Therapeutics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Asthma Therapeutics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Inhalation
1.2.3 Parenteral
1.2.4 Oral
1.3 Market by Application
1.3.1 Global Asthma Therapeutics Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Clinics
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Asthma Therapeutics Market Perspective (2020-2031)
2.2 Global Asthma Therapeutics Growth Trends by Region
2.2.1 Global Asthma Therapeutics Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Asthma Therapeutics Historic Market Size by Region (2020-2025)
2.2.3 Asthma Therapeutics Forecasted Market Size by Region (2026-2031)
2.3 Asthma Therapeutics Market Dynamics
2.3.1 Asthma Therapeutics Industry Trends
2.3.2 Asthma Therapeutics Market Drivers
2.3.3 Asthma Therapeutics Market Challenges
2.3.4 Asthma Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Asthma Therapeutics Players by Revenue
3.1.1 Global Top Asthma Therapeutics Players by Revenue (2020-2025)
3.1.2 Global Asthma Therapeutics Revenue Market Share by Players (2020-2025)
3.2 Global Asthma Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Asthma Therapeutics Revenue
3.4 Global Asthma Therapeutics Market Concentration Ratio
3.4.1 Global Asthma Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Asthma Therapeutics Revenue in 2024
3.5 Global Key Players of Asthma Therapeutics Head office and Area Served
3.6 Global Key Players of Asthma Therapeutics, Product and Application
3.7 Global Key Players of Asthma Therapeutics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Asthma Therapeutics Breakdown Data by Type
4.1 Global Asthma Therapeutics Historic Market Size by Type (2020-2025)
4.2 Global Asthma Therapeutics Forecasted Market Size by Type (2026-2031)
5 Asthma Therapeutics Breakdown Data by Application
5.1 Global Asthma Therapeutics Historic Market Size by Application (2020-2025)
5.2 Global Asthma Therapeutics Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Asthma Therapeutics Market Size (2020-2031)
6.2 North America Asthma Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Asthma Therapeutics Market Size by Country (2020-2025)
6.4 North America Asthma Therapeutics Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Asthma Therapeutics Market Size (2020-2031)
7.2 Europe Asthma Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Asthma Therapeutics Market Size by Country (2020-2025)
7.4 Europe Asthma Therapeutics Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Asthma Therapeutics Market Size (2020-2031)
8.2 Asia-Pacific Asthma Therapeutics Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Asthma Therapeutics Market Size by Region (2020-2025)
8.4 Asia-Pacific Asthma Therapeutics Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Asthma Therapeutics Market Size (2020-2031)
9.2 Latin America Asthma Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Asthma Therapeutics Market Size by Country (2020-2025)
9.4 Latin America Asthma Therapeutics Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Asthma Therapeutics Market Size (2020-2031)
10.2 Middle East & Africa Asthma Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Asthma Therapeutics Market Size by Country (2020-2025)
10.4 Middle East & Africa Asthma Therapeutics Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 AstraZeneca
11.1.1 AstraZeneca Company Details
11.1.2 AstraZeneca Business Overview
11.1.3 AstraZeneca Asthma Therapeutics Introduction
11.1.4 AstraZeneca Revenue in Asthma Therapeutics Business (2020-2025)
11.1.5 AstraZeneca Recent Development
11.2 Boehringer Ingelheim
11.2.1 Boehringer Ingelheim Company Details
11.2.2 Boehringer Ingelheim Business Overview
11.2.3 Boehringer Ingelheim Asthma Therapeutics Introduction
11.2.4 Boehringer Ingelheim Revenue in Asthma Therapeutics Business (2020-2025)
11.2.5 Boehringer Ingelheim Recent Development
11.3 F. Hoffmann-La Roche
11.3.1 F. Hoffmann-La Roche Company Details
11.3.2 F. Hoffmann-La Roche Business Overview
11.3.3 F. Hoffmann-La Roche Asthma Therapeutics Introduction
11.3.4 F. Hoffmann-La Roche Revenue in Asthma Therapeutics Business (2020-2025)
11.3.5 F. Hoffmann-La Roche Recent Development
11.4 GSK
11.4.1 GSK Company Details
11.4.2 GSK Business Overview
11.4.3 GSK Asthma Therapeutics Introduction
11.4.4 GSK Revenue in Asthma Therapeutics Business (2020-2025)
11.4.5 GSK Recent Development
11.5 Merck
11.5.1 Merck Company Details
11.5.2 Merck Business Overview
11.5.3 Merck Asthma Therapeutics Introduction
11.5.4 Merck Revenue in Asthma Therapeutics Business (2020-2025)
11.5.5 Merck Recent Development
11.6 Horizon Pharma
11.6.1 Horizon Pharma Company Details
11.6.2 Horizon Pharma Business Overview
11.6.3 Horizon Pharma Asthma Therapeutics Introduction
11.6.4 Horizon Pharma Revenue in Asthma Therapeutics Business (2020-2025)
11.6.5 Horizon Pharma Recent Development
11.7 Mitsubishi Tanabe Pharma
11.7.1 Mitsubishi Tanabe Pharma Company Details
11.7.2 Mitsubishi Tanabe Pharma Business Overview
11.7.3 Mitsubishi Tanabe Pharma Asthma Therapeutics Introduction
11.7.4 Mitsubishi Tanabe Pharma Revenue in Asthma Therapeutics Business (2020-2025)
11.7.5 Mitsubishi Tanabe Pharma Recent Development
11.8 Sanofi
11.8.1 Sanofi Company Details
11.8.2 Sanofi Business Overview
11.8.3 Sanofi Asthma Therapeutics Introduction
11.8.4 Sanofi Revenue in Asthma Therapeutics Business (2020-2025)
11.8.5 Sanofi Recent Development
11.9 Mundipharma
11.9.1 Mundipharma Company Details
11.9.2 Mundipharma Business Overview
11.9.3 Mundipharma Asthma Therapeutics Introduction
11.9.4 Mundipharma Revenue in Asthma Therapeutics Business (2020-2025)
11.9.5 Mundipharma Recent Development
11.10 Nycomed
11.10.1 Nycomed Company Details
11.10.2 Nycomed Business Overview
11.10.3 Nycomed Asthma Therapeutics Introduction
11.10.4 Nycomed Revenue in Asthma Therapeutics Business (2020-2025)
11.10.5 Nycomed Recent Development
11.11 Kissei Pharmaceutical
11.11.1 Kissei Pharmaceutical Company Details
11.11.2 Kissei Pharmaceutical Business Overview
11.11.3 Kissei Pharmaceutical Asthma Therapeutics Introduction
11.11.4 Kissei Pharmaceutical Revenue in Asthma Therapeutics Business (2020-2025)
11.11.5 Kissei Pharmaceutical Recent Development
11.12 ALK-Abello
11.12.1 ALK-Abello Company Details
11.12.2 ALK-Abello Business Overview
11.12.3 ALK-Abello Asthma Therapeutics Introduction
11.12.4 ALK-Abello Revenue in Asthma Therapeutics Business (2020-2025)
11.12.5 ALK-Abello Recent Development
11.13 Array BioPharma
11.13.1 Array BioPharma Company Details
11.13.2 Array BioPharma Business Overview
11.13.3 Array BioPharma Asthma Therapeutics Introduction
11.13.4 Array BioPharma Revenue in Asthma Therapeutics Business (2020-2025)
11.13.5 Array BioPharma Recent Development
11.14 SAMA Pharmaceuticals
11.14.1 SAMA Pharmaceuticals Company Details
11.14.2 SAMA Pharmaceuticals Business Overview
11.14.3 SAMA Pharmaceuticals Asthma Therapeutics Introduction
11.14.4 SAMA Pharmaceuticals Revenue in Asthma Therapeutics Business (2020-2025)
11.14.5 SAMA Pharmaceuticals Recent Development
11.15 Whanin Pharmaceutical
11.15.1 Whanin Pharmaceutical Company Details
11.15.2 Whanin Pharmaceutical Business Overview
11.15.3 Whanin Pharmaceutical Asthma Therapeutics Introduction
11.15.4 Whanin Pharmaceutical Revenue in Asthma Therapeutics Business (2020-2025)
11.15.5 Whanin Pharmaceutical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Asthma Therapeutics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Inhalation
1.2.3 Parenteral
1.2.4 Oral
1.3 Market by Application
1.3.1 Global Asthma Therapeutics Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Clinics
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Asthma Therapeutics Market Perspective (2020-2031)
2.2 Global Asthma Therapeutics Growth Trends by Region
2.2.1 Global Asthma Therapeutics Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Asthma Therapeutics Historic Market Size by Region (2020-2025)
2.2.3 Asthma Therapeutics Forecasted Market Size by Region (2026-2031)
2.3 Asthma Therapeutics Market Dynamics
2.3.1 Asthma Therapeutics Industry Trends
2.3.2 Asthma Therapeutics Market Drivers
2.3.3 Asthma Therapeutics Market Challenges
2.3.4 Asthma Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Asthma Therapeutics Players by Revenue
3.1.1 Global Top Asthma Therapeutics Players by Revenue (2020-2025)
3.1.2 Global Asthma Therapeutics Revenue Market Share by Players (2020-2025)
3.2 Global Asthma Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Asthma Therapeutics Revenue
3.4 Global Asthma Therapeutics Market Concentration Ratio
3.4.1 Global Asthma Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Asthma Therapeutics Revenue in 2024
3.5 Global Key Players of Asthma Therapeutics Head office and Area Served
3.6 Global Key Players of Asthma Therapeutics, Product and Application
3.7 Global Key Players of Asthma Therapeutics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Asthma Therapeutics Breakdown Data by Type
4.1 Global Asthma Therapeutics Historic Market Size by Type (2020-2025)
4.2 Global Asthma Therapeutics Forecasted Market Size by Type (2026-2031)
5 Asthma Therapeutics Breakdown Data by Application
5.1 Global Asthma Therapeutics Historic Market Size by Application (2020-2025)
5.2 Global Asthma Therapeutics Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Asthma Therapeutics Market Size (2020-2031)
6.2 North America Asthma Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Asthma Therapeutics Market Size by Country (2020-2025)
6.4 North America Asthma Therapeutics Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Asthma Therapeutics Market Size (2020-2031)
7.2 Europe Asthma Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Asthma Therapeutics Market Size by Country (2020-2025)
7.4 Europe Asthma Therapeutics Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Asthma Therapeutics Market Size (2020-2031)
8.2 Asia-Pacific Asthma Therapeutics Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Asthma Therapeutics Market Size by Region (2020-2025)
8.4 Asia-Pacific Asthma Therapeutics Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Asthma Therapeutics Market Size (2020-2031)
9.2 Latin America Asthma Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Asthma Therapeutics Market Size by Country (2020-2025)
9.4 Latin America Asthma Therapeutics Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Asthma Therapeutics Market Size (2020-2031)
10.2 Middle East & Africa Asthma Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Asthma Therapeutics Market Size by Country (2020-2025)
10.4 Middle East & Africa Asthma Therapeutics Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 AstraZeneca
11.1.1 AstraZeneca Company Details
11.1.2 AstraZeneca Business Overview
11.1.3 AstraZeneca Asthma Therapeutics Introduction
11.1.4 AstraZeneca Revenue in Asthma Therapeutics Business (2020-2025)
11.1.5 AstraZeneca Recent Development
11.2 Boehringer Ingelheim
11.2.1 Boehringer Ingelheim Company Details
11.2.2 Boehringer Ingelheim Business Overview
11.2.3 Boehringer Ingelheim Asthma Therapeutics Introduction
11.2.4 Boehringer Ingelheim Revenue in Asthma Therapeutics Business (2020-2025)
11.2.5 Boehringer Ingelheim Recent Development
11.3 F. Hoffmann-La Roche
11.3.1 F. Hoffmann-La Roche Company Details
11.3.2 F. Hoffmann-La Roche Business Overview
11.3.3 F. Hoffmann-La Roche Asthma Therapeutics Introduction
11.3.4 F. Hoffmann-La Roche Revenue in Asthma Therapeutics Business (2020-2025)
11.3.5 F. Hoffmann-La Roche Recent Development
11.4 GSK
11.4.1 GSK Company Details
11.4.2 GSK Business Overview
11.4.3 GSK Asthma Therapeutics Introduction
11.4.4 GSK Revenue in Asthma Therapeutics Business (2020-2025)
11.4.5 GSK Recent Development
11.5 Merck
11.5.1 Merck Company Details
11.5.2 Merck Business Overview
11.5.3 Merck Asthma Therapeutics Introduction
11.5.4 Merck Revenue in Asthma Therapeutics Business (2020-2025)
11.5.5 Merck Recent Development
11.6 Horizon Pharma
11.6.1 Horizon Pharma Company Details
11.6.2 Horizon Pharma Business Overview
11.6.3 Horizon Pharma Asthma Therapeutics Introduction
11.6.4 Horizon Pharma Revenue in Asthma Therapeutics Business (2020-2025)
11.6.5 Horizon Pharma Recent Development
11.7 Mitsubishi Tanabe Pharma
11.7.1 Mitsubishi Tanabe Pharma Company Details
11.7.2 Mitsubishi Tanabe Pharma Business Overview
11.7.3 Mitsubishi Tanabe Pharma Asthma Therapeutics Introduction
11.7.4 Mitsubishi Tanabe Pharma Revenue in Asthma Therapeutics Business (2020-2025)
11.7.5 Mitsubishi Tanabe Pharma Recent Development
11.8 Sanofi
11.8.1 Sanofi Company Details
11.8.2 Sanofi Business Overview
11.8.3 Sanofi Asthma Therapeutics Introduction
11.8.4 Sanofi Revenue in Asthma Therapeutics Business (2020-2025)
11.8.5 Sanofi Recent Development
11.9 Mundipharma
11.9.1 Mundipharma Company Details
11.9.2 Mundipharma Business Overview
11.9.3 Mundipharma Asthma Therapeutics Introduction
11.9.4 Mundipharma Revenue in Asthma Therapeutics Business (2020-2025)
11.9.5 Mundipharma Recent Development
11.10 Nycomed
11.10.1 Nycomed Company Details
11.10.2 Nycomed Business Overview
11.10.3 Nycomed Asthma Therapeutics Introduction
11.10.4 Nycomed Revenue in Asthma Therapeutics Business (2020-2025)
11.10.5 Nycomed Recent Development
11.11 Kissei Pharmaceutical
11.11.1 Kissei Pharmaceutical Company Details
11.11.2 Kissei Pharmaceutical Business Overview
11.11.3 Kissei Pharmaceutical Asthma Therapeutics Introduction
11.11.4 Kissei Pharmaceutical Revenue in Asthma Therapeutics Business (2020-2025)
11.11.5 Kissei Pharmaceutical Recent Development
11.12 ALK-Abello
11.12.1 ALK-Abello Company Details
11.12.2 ALK-Abello Business Overview
11.12.3 ALK-Abello Asthma Therapeutics Introduction
11.12.4 ALK-Abello Revenue in Asthma Therapeutics Business (2020-2025)
11.12.5 ALK-Abello Recent Development
11.13 Array BioPharma
11.13.1 Array BioPharma Company Details
11.13.2 Array BioPharma Business Overview
11.13.3 Array BioPharma Asthma Therapeutics Introduction
11.13.4 Array BioPharma Revenue in Asthma Therapeutics Business (2020-2025)
11.13.5 Array BioPharma Recent Development
11.14 SAMA Pharmaceuticals
11.14.1 SAMA Pharmaceuticals Company Details
11.14.2 SAMA Pharmaceuticals Business Overview
11.14.3 SAMA Pharmaceuticals Asthma Therapeutics Introduction
11.14.4 SAMA Pharmaceuticals Revenue in Asthma Therapeutics Business (2020-2025)
11.14.5 SAMA Pharmaceuticals Recent Development
11.15 Whanin Pharmaceutical
11.15.1 Whanin Pharmaceutical Company Details
11.15.2 Whanin Pharmaceutical Business Overview
11.15.3 Whanin Pharmaceutical Asthma Therapeutics Introduction
11.15.4 Whanin Pharmaceutical Revenue in Asthma Therapeutics Business (2020-2025)
11.15.5 Whanin Pharmaceutical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Asthma Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Inhalation
Table 3. Key Players of Parenteral
Table 4. Key Players of Oral
Table 5. Global Asthma Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Asthma Therapeutics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Asthma Therapeutics Market Size by Region (2020-2025) & (US$ Million)
Table 8. Global Asthma Therapeutics Market Share by Region (2020-2025)
Table 9. Global Asthma Therapeutics Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 10. Global Asthma Therapeutics Market Share by Region (2026-2031)
Table 11. Asthma Therapeutics Market Trends
Table 12. Asthma Therapeutics Market Drivers
Table 13. Asthma Therapeutics Market Challenges
Table 14. Asthma Therapeutics Market Restraints
Table 15. Global Asthma Therapeutics Revenue by Players (2020-2025) & (US$ Million)
Table 16. Global Asthma Therapeutics Market Share by Players (2020-2025)
Table 17. Global Top Asthma Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Asthma Therapeutics as of 2024)
Table 18. Ranking of Global Top Asthma Therapeutics Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by Asthma Therapeutics Revenue (CR5 and HHI) & (2020-2025)
Table 20. Global Key Players of Asthma Therapeutics, Headquarters and Area Served
Table 21. Global Key Players of Asthma Therapeutics, Product and Application
Table 22. Global Key Players of Asthma Therapeutics, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Asthma Therapeutics Market Size by Type (2020-2025) & (US$ Million)
Table 25. Global Asthma Therapeutics Revenue Market Share by Type (2020-2025)
Table 26. Global Asthma Therapeutics Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 27. Global Asthma Therapeutics Revenue Market Share by Type (2026-2031)
Table 28. Global Asthma Therapeutics Market Size by Application (2020-2025) & (US$ Million)
Table 29. Global Asthma Therapeutics Revenue Market Share by Application (2020-2025)
Table 30. Global Asthma Therapeutics Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 31. Global Asthma Therapeutics Revenue Market Share by Application (2026-2031)
Table 32. North America Asthma Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America Asthma Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 34. North America Asthma Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 35. Europe Asthma Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. Europe Asthma Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 37. Europe Asthma Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 38. Asia-Pacific Asthma Therapeutics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 39. Asia-Pacific Asthma Therapeutics Market Size by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific Asthma Therapeutics Market Size by Region (2026-2031) & (US$ Million)
Table 41. Latin America Asthma Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. Latin America Asthma Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 43. Latin America Asthma Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 44. Middle East & Africa Asthma Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Middle East & Africa Asthma Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 46. Middle East & Africa Asthma Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 47. AstraZeneca Company Details
Table 48. AstraZeneca Business Overview
Table 49. AstraZeneca Asthma Therapeutics Product
Table 50. AstraZeneca Revenue in Asthma Therapeutics Business (2020-2025) & (US$ Million)
Table 51. AstraZeneca Recent Development
Table 52. Boehringer Ingelheim Company Details
Table 53. Boehringer Ingelheim Business Overview
Table 54. Boehringer Ingelheim Asthma Therapeutics Product
Table 55. Boehringer Ingelheim Revenue in Asthma Therapeutics Business (2020-2025) & (US$ Million)
Table 56. Boehringer Ingelheim Recent Development
Table 57. F. Hoffmann-La Roche Company Details
Table 58. F. Hoffmann-La Roche Business Overview
Table 59. F. Hoffmann-La Roche Asthma Therapeutics Product
Table 60. F. Hoffmann-La Roche Revenue in Asthma Therapeutics Business (2020-2025) & (US$ Million)
Table 61. F. Hoffmann-La Roche Recent Development
Table 62. GSK Company Details
Table 63. GSK Business Overview
Table 64. GSK Asthma Therapeutics Product
Table 65. GSK Revenue in Asthma Therapeutics Business (2020-2025) & (US$ Million)
Table 66. GSK Recent Development
Table 67. Merck Company Details
Table 68. Merck Business Overview
Table 69. Merck Asthma Therapeutics Product
Table 70. Merck Revenue in Asthma Therapeutics Business (2020-2025) & (US$ Million)
Table 71. Merck Recent Development
Table 72. Horizon Pharma Company Details
Table 73. Horizon Pharma Business Overview
Table 74. Horizon Pharma Asthma Therapeutics Product
Table 75. Horizon Pharma Revenue in Asthma Therapeutics Business (2020-2025) & (US$ Million)
Table 76. Horizon Pharma Recent Development
Table 77. Mitsubishi Tanabe Pharma Company Details
Table 78. Mitsubishi Tanabe Pharma Business Overview
Table 79. Mitsubishi Tanabe Pharma Asthma Therapeutics Product
Table 80. Mitsubishi Tanabe Pharma Revenue in Asthma Therapeutics Business (2020-2025) & (US$ Million)
Table 81. Mitsubishi Tanabe Pharma Recent Development
Table 82. Sanofi Company Details
Table 83. Sanofi Business Overview
Table 84. Sanofi Asthma Therapeutics Product
Table 85. Sanofi Revenue in Asthma Therapeutics Business (2020-2025) & (US$ Million)
Table 86. Sanofi Recent Development
Table 87. Mundipharma Company Details
Table 88. Mundipharma Business Overview
Table 89. Mundipharma Asthma Therapeutics Product
Table 90. Mundipharma Revenue in Asthma Therapeutics Business (2020-2025) & (US$ Million)
Table 91. Mundipharma Recent Development
Table 92. Nycomed Company Details
Table 93. Nycomed Business Overview
Table 94. Nycomed Asthma Therapeutics Product
Table 95. Nycomed Revenue in Asthma Therapeutics Business (2020-2025) & (US$ Million)
Table 96. Nycomed Recent Development
Table 97. Kissei Pharmaceutical Company Details
Table 98. Kissei Pharmaceutical Business Overview
Table 99. Kissei Pharmaceutical Asthma Therapeutics Product
Table 100. Kissei Pharmaceutical Revenue in Asthma Therapeutics Business (2020-2025) & (US$ Million)
Table 101. Kissei Pharmaceutical Recent Development
Table 102. ALK-Abello Company Details
Table 103. ALK-Abello Business Overview
Table 104. ALK-Abello Asthma Therapeutics Product
Table 105. ALK-Abello Revenue in Asthma Therapeutics Business (2020-2025) & (US$ Million)
Table 106. ALK-Abello Recent Development
Table 107. Array BioPharma Company Details
Table 108. Array BioPharma Business Overview
Table 109. Array BioPharma Asthma Therapeutics Product
Table 110. Array BioPharma Revenue in Asthma Therapeutics Business (2020-2025) & (US$ Million)
Table 111. Array BioPharma Recent Development
Table 112. SAMA Pharmaceuticals Company Details
Table 113. SAMA Pharmaceuticals Business Overview
Table 114. SAMA Pharmaceuticals Asthma Therapeutics Product
Table 115. SAMA Pharmaceuticals Revenue in Asthma Therapeutics Business (2020-2025) & (US$ Million)
Table 116. SAMA Pharmaceuticals Recent Development
Table 117. Whanin Pharmaceutical Company Details
Table 118. Whanin Pharmaceutical Business Overview
Table 119. Whanin Pharmaceutical Asthma Therapeutics Product
Table 120. Whanin Pharmaceutical Revenue in Asthma Therapeutics Business (2020-2025) & (US$ Million)
Table 121. Whanin Pharmaceutical Recent Development
Table 122. Research Programs/Design for This Report
Table 123. Key Data Information from Secondary Sources
Table 124. Key Data Information from Primary Sources
Table 125. Authors List of This Report
List of Figures
Figure 1. Asthma Therapeutics Picture
Figure 2. Global Asthma Therapeutics Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Asthma Therapeutics Market Share by Type: 2024 VS 2031
Figure 4. Inhalation Features
Figure 5. Parenteral Features
Figure 6. Oral Features
Figure 7. Global Asthma Therapeutics Market Size by Application (2020-2031) & (US$ Million)
Figure 8. Global Asthma Therapeutics Market Share by Application: 2024 VS 2031
Figure 9. Hospitals Case Studies
Figure 10. Clinics Case Studies
Figure 11. Asthma Therapeutics Report Years Considered
Figure 12. Global Asthma Therapeutics Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global Asthma Therapeutics Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Asthma Therapeutics Market Share by Region: 2024 VS 2031
Figure 15. Global Asthma Therapeutics Market Share by Players in 2024
Figure 16. Global Top Asthma Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Asthma Therapeutics as of 2024)
Figure 17. The Top 10 and 5 Players Market Share by Asthma Therapeutics Revenue in 2024
Figure 18. North America Asthma Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 19. North America Asthma Therapeutics Market Share by Country (2020-2031)
Figure 20. United States Asthma Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Canada Asthma Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Asthma Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Asthma Therapeutics Market Share by Country (2020-2031)
Figure 24. Germany Asthma Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. France Asthma Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. U.K. Asthma Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Italy Asthma Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Russia Asthma Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Nordic Countries Asthma Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Asthma Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Asthma Therapeutics Market Share by Region (2020-2031)
Figure 32. China Asthma Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Japan Asthma Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. South Korea Asthma Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Southeast Asia Asthma Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. India Asthma Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Australia Asthma Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Asthma Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Asthma Therapeutics Market Share by Country (2020-2031)
Figure 40. Mexico Asthma Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Brazil Asthma Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Asthma Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Asthma Therapeutics Market Share by Country (2020-2031)
Figure 44. Turkey Asthma Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Saudi Arabia Asthma Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. UAE Asthma Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. AstraZeneca Revenue Growth Rate in Asthma Therapeutics Business (2020-2025)
Figure 48. Boehringer Ingelheim Revenue Growth Rate in Asthma Therapeutics Business (2020-2025)
Figure 49. F. Hoffmann-La Roche Revenue Growth Rate in Asthma Therapeutics Business (2020-2025)
Figure 50. GSK Revenue Growth Rate in Asthma Therapeutics Business (2020-2025)
Figure 51. Merck Revenue Growth Rate in Asthma Therapeutics Business (2020-2025)
Figure 52. Horizon Pharma Revenue Growth Rate in Asthma Therapeutics Business (2020-2025)
Figure 53. Mitsubishi Tanabe Pharma Revenue Growth Rate in Asthma Therapeutics Business (2020-2025)
Figure 54. Sanofi Revenue Growth Rate in Asthma Therapeutics Business (2020-2025)
Figure 55. Mundipharma Revenue Growth Rate in Asthma Therapeutics Business (2020-2025)
Figure 56. Nycomed Revenue Growth Rate in Asthma Therapeutics Business (2020-2025)
Figure 57. Kissei Pharmaceutical Revenue Growth Rate in Asthma Therapeutics Business (2020-2025)
Figure 58. ALK-Abello Revenue Growth Rate in Asthma Therapeutics Business (2020-2025)
Figure 59. Array BioPharma Revenue Growth Rate in Asthma Therapeutics Business (2020-2025)
Figure 60. SAMA Pharmaceuticals Revenue Growth Rate in Asthma Therapeutics Business (2020-2025)
Figure 61. Whanin Pharmaceutical Revenue Growth Rate in Asthma Therapeutics Business (2020-2025)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Table 1. Global Asthma Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Inhalation
Table 3. Key Players of Parenteral
Table 4. Key Players of Oral
Table 5. Global Asthma Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Asthma Therapeutics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Asthma Therapeutics Market Size by Region (2020-2025) & (US$ Million)
Table 8. Global Asthma Therapeutics Market Share by Region (2020-2025)
Table 9. Global Asthma Therapeutics Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 10. Global Asthma Therapeutics Market Share by Region (2026-2031)
Table 11. Asthma Therapeutics Market Trends
Table 12. Asthma Therapeutics Market Drivers
Table 13. Asthma Therapeutics Market Challenges
Table 14. Asthma Therapeutics Market Restraints
Table 15. Global Asthma Therapeutics Revenue by Players (2020-2025) & (US$ Million)
Table 16. Global Asthma Therapeutics Market Share by Players (2020-2025)
Table 17. Global Top Asthma Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Asthma Therapeutics as of 2024)
Table 18. Ranking of Global Top Asthma Therapeutics Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by Asthma Therapeutics Revenue (CR5 and HHI) & (2020-2025)
Table 20. Global Key Players of Asthma Therapeutics, Headquarters and Area Served
Table 21. Global Key Players of Asthma Therapeutics, Product and Application
Table 22. Global Key Players of Asthma Therapeutics, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Asthma Therapeutics Market Size by Type (2020-2025) & (US$ Million)
Table 25. Global Asthma Therapeutics Revenue Market Share by Type (2020-2025)
Table 26. Global Asthma Therapeutics Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 27. Global Asthma Therapeutics Revenue Market Share by Type (2026-2031)
Table 28. Global Asthma Therapeutics Market Size by Application (2020-2025) & (US$ Million)
Table 29. Global Asthma Therapeutics Revenue Market Share by Application (2020-2025)
Table 30. Global Asthma Therapeutics Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 31. Global Asthma Therapeutics Revenue Market Share by Application (2026-2031)
Table 32. North America Asthma Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America Asthma Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 34. North America Asthma Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 35. Europe Asthma Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. Europe Asthma Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 37. Europe Asthma Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 38. Asia-Pacific Asthma Therapeutics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 39. Asia-Pacific Asthma Therapeutics Market Size by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific Asthma Therapeutics Market Size by Region (2026-2031) & (US$ Million)
Table 41. Latin America Asthma Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. Latin America Asthma Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 43. Latin America Asthma Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 44. Middle East & Africa Asthma Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Middle East & Africa Asthma Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 46. Middle East & Africa Asthma Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 47. AstraZeneca Company Details
Table 48. AstraZeneca Business Overview
Table 49. AstraZeneca Asthma Therapeutics Product
Table 50. AstraZeneca Revenue in Asthma Therapeutics Business (2020-2025) & (US$ Million)
Table 51. AstraZeneca Recent Development
Table 52. Boehringer Ingelheim Company Details
Table 53. Boehringer Ingelheim Business Overview
Table 54. Boehringer Ingelheim Asthma Therapeutics Product
Table 55. Boehringer Ingelheim Revenue in Asthma Therapeutics Business (2020-2025) & (US$ Million)
Table 56. Boehringer Ingelheim Recent Development
Table 57. F. Hoffmann-La Roche Company Details
Table 58. F. Hoffmann-La Roche Business Overview
Table 59. F. Hoffmann-La Roche Asthma Therapeutics Product
Table 60. F. Hoffmann-La Roche Revenue in Asthma Therapeutics Business (2020-2025) & (US$ Million)
Table 61. F. Hoffmann-La Roche Recent Development
Table 62. GSK Company Details
Table 63. GSK Business Overview
Table 64. GSK Asthma Therapeutics Product
Table 65. GSK Revenue in Asthma Therapeutics Business (2020-2025) & (US$ Million)
Table 66. GSK Recent Development
Table 67. Merck Company Details
Table 68. Merck Business Overview
Table 69. Merck Asthma Therapeutics Product
Table 70. Merck Revenue in Asthma Therapeutics Business (2020-2025) & (US$ Million)
Table 71. Merck Recent Development
Table 72. Horizon Pharma Company Details
Table 73. Horizon Pharma Business Overview
Table 74. Horizon Pharma Asthma Therapeutics Product
Table 75. Horizon Pharma Revenue in Asthma Therapeutics Business (2020-2025) & (US$ Million)
Table 76. Horizon Pharma Recent Development
Table 77. Mitsubishi Tanabe Pharma Company Details
Table 78. Mitsubishi Tanabe Pharma Business Overview
Table 79. Mitsubishi Tanabe Pharma Asthma Therapeutics Product
Table 80. Mitsubishi Tanabe Pharma Revenue in Asthma Therapeutics Business (2020-2025) & (US$ Million)
Table 81. Mitsubishi Tanabe Pharma Recent Development
Table 82. Sanofi Company Details
Table 83. Sanofi Business Overview
Table 84. Sanofi Asthma Therapeutics Product
Table 85. Sanofi Revenue in Asthma Therapeutics Business (2020-2025) & (US$ Million)
Table 86. Sanofi Recent Development
Table 87. Mundipharma Company Details
Table 88. Mundipharma Business Overview
Table 89. Mundipharma Asthma Therapeutics Product
Table 90. Mundipharma Revenue in Asthma Therapeutics Business (2020-2025) & (US$ Million)
Table 91. Mundipharma Recent Development
Table 92. Nycomed Company Details
Table 93. Nycomed Business Overview
Table 94. Nycomed Asthma Therapeutics Product
Table 95. Nycomed Revenue in Asthma Therapeutics Business (2020-2025) & (US$ Million)
Table 96. Nycomed Recent Development
Table 97. Kissei Pharmaceutical Company Details
Table 98. Kissei Pharmaceutical Business Overview
Table 99. Kissei Pharmaceutical Asthma Therapeutics Product
Table 100. Kissei Pharmaceutical Revenue in Asthma Therapeutics Business (2020-2025) & (US$ Million)
Table 101. Kissei Pharmaceutical Recent Development
Table 102. ALK-Abello Company Details
Table 103. ALK-Abello Business Overview
Table 104. ALK-Abello Asthma Therapeutics Product
Table 105. ALK-Abello Revenue in Asthma Therapeutics Business (2020-2025) & (US$ Million)
Table 106. ALK-Abello Recent Development
Table 107. Array BioPharma Company Details
Table 108. Array BioPharma Business Overview
Table 109. Array BioPharma Asthma Therapeutics Product
Table 110. Array BioPharma Revenue in Asthma Therapeutics Business (2020-2025) & (US$ Million)
Table 111. Array BioPharma Recent Development
Table 112. SAMA Pharmaceuticals Company Details
Table 113. SAMA Pharmaceuticals Business Overview
Table 114. SAMA Pharmaceuticals Asthma Therapeutics Product
Table 115. SAMA Pharmaceuticals Revenue in Asthma Therapeutics Business (2020-2025) & (US$ Million)
Table 116. SAMA Pharmaceuticals Recent Development
Table 117. Whanin Pharmaceutical Company Details
Table 118. Whanin Pharmaceutical Business Overview
Table 119. Whanin Pharmaceutical Asthma Therapeutics Product
Table 120. Whanin Pharmaceutical Revenue in Asthma Therapeutics Business (2020-2025) & (US$ Million)
Table 121. Whanin Pharmaceutical Recent Development
Table 122. Research Programs/Design for This Report
Table 123. Key Data Information from Secondary Sources
Table 124. Key Data Information from Primary Sources
Table 125. Authors List of This Report
List of Figures
Figure 1. Asthma Therapeutics Picture
Figure 2. Global Asthma Therapeutics Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Asthma Therapeutics Market Share by Type: 2024 VS 2031
Figure 4. Inhalation Features
Figure 5. Parenteral Features
Figure 6. Oral Features
Figure 7. Global Asthma Therapeutics Market Size by Application (2020-2031) & (US$ Million)
Figure 8. Global Asthma Therapeutics Market Share by Application: 2024 VS 2031
Figure 9. Hospitals Case Studies
Figure 10. Clinics Case Studies
Figure 11. Asthma Therapeutics Report Years Considered
Figure 12. Global Asthma Therapeutics Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global Asthma Therapeutics Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Asthma Therapeutics Market Share by Region: 2024 VS 2031
Figure 15. Global Asthma Therapeutics Market Share by Players in 2024
Figure 16. Global Top Asthma Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Asthma Therapeutics as of 2024)
Figure 17. The Top 10 and 5 Players Market Share by Asthma Therapeutics Revenue in 2024
Figure 18. North America Asthma Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 19. North America Asthma Therapeutics Market Share by Country (2020-2031)
Figure 20. United States Asthma Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Canada Asthma Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Asthma Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Asthma Therapeutics Market Share by Country (2020-2031)
Figure 24. Germany Asthma Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. France Asthma Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. U.K. Asthma Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Italy Asthma Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Russia Asthma Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Nordic Countries Asthma Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Asthma Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Asthma Therapeutics Market Share by Region (2020-2031)
Figure 32. China Asthma Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Japan Asthma Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. South Korea Asthma Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Southeast Asia Asthma Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. India Asthma Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Australia Asthma Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Asthma Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Asthma Therapeutics Market Share by Country (2020-2031)
Figure 40. Mexico Asthma Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Brazil Asthma Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Asthma Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Asthma Therapeutics Market Share by Country (2020-2031)
Figure 44. Turkey Asthma Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Saudi Arabia Asthma Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. UAE Asthma Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. AstraZeneca Revenue Growth Rate in Asthma Therapeutics Business (2020-2025)
Figure 48. Boehringer Ingelheim Revenue Growth Rate in Asthma Therapeutics Business (2020-2025)
Figure 49. F. Hoffmann-La Roche Revenue Growth Rate in Asthma Therapeutics Business (2020-2025)
Figure 50. GSK Revenue Growth Rate in Asthma Therapeutics Business (2020-2025)
Figure 51. Merck Revenue Growth Rate in Asthma Therapeutics Business (2020-2025)
Figure 52. Horizon Pharma Revenue Growth Rate in Asthma Therapeutics Business (2020-2025)
Figure 53. Mitsubishi Tanabe Pharma Revenue Growth Rate in Asthma Therapeutics Business (2020-2025)
Figure 54. Sanofi Revenue Growth Rate in Asthma Therapeutics Business (2020-2025)
Figure 55. Mundipharma Revenue Growth Rate in Asthma Therapeutics Business (2020-2025)
Figure 56. Nycomed Revenue Growth Rate in Asthma Therapeutics Business (2020-2025)
Figure 57. Kissei Pharmaceutical Revenue Growth Rate in Asthma Therapeutics Business (2020-2025)
Figure 58. ALK-Abello Revenue Growth Rate in Asthma Therapeutics Business (2020-2025)
Figure 59. Array BioPharma Revenue Growth Rate in Asthma Therapeutics Business (2020-2025)
Figure 60. SAMA Pharmaceuticals Revenue Growth Rate in Asthma Therapeutics Business (2020-2025)
Figure 61. Whanin Pharmaceutical Revenue Growth Rate in Asthma Therapeutics Business (2020-2025)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Multi-Channel Temperature Controllers Market Research Report 2025
Mar 14, 25
Global Waterproof Action Cameras Market Research Report 2025
Mar 14, 25
Global Infrared IP Cameras Market Research Report 2025
Mar 14, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232